Abstract: A method for measuring an intracranial bioimpedance in a patient's head, to help evaluate cerebral autoregulation, may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, measuring the intracranial bioimpedance with the VIPS device by measuring a phase shift between a magnetic field transmitted from a transmitter on one side of a VIPS device and a magnetic field received at a receiver on another side of the VIPS device, at one or more frequencies, and evaluating cerebral autoregulation in the intracranial bioimpedance, using a processor in the VIPS device.

Abstract: A method for detecting evidence of a stroke in a patient may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, transmitting a first signal from a first transmitter of the VIPS device through a left hemisphere of the patient's brain to a receiver of the VIPS device, transmitting a second signal from a second transmitter of the VIPS device through a right hemisphere of the patient's brain to the receiver, and detecting the evidence of the stroke, with the VIPS device.

Abstract: A method for assessing a patient may involve performing a first diagnostic procedure on the patient. The first diagnostic procedure may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, measuring an intracranial bioimpedance with the VIPS device, and detecting an asymmetry based on the measured intracranial bioimpedance. The method may further involve performing a second diagnostic procedure on the patient using an additional diagnostic device, receiving first patient data from the first diagnostic procedure and second patient data from the second diagnostic procedure in a computer processor, processing the first patient data and the second patient data with the computer processor, and generating an assessment of the patient with the computer processor, based at least in part on the processed first patient data and second patient data.

Abstract: A method for measuring an intracranial bioimpedance in a patient's head, to help evaluate cerebral autoregulation, may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, measuring the intracranial bioimpedance with the VIPS device by measuring a phase shift between a magnetic field transmitted from a transmitter on one side of a VIPS device and a magnetic field received at a receiver on another side of the VIPS device, at one or more frequencies, and evaluating cerebral autoregulation in the intracranial bioimpedance, using a processor in the VIPS device.

Abstract: A method for measuring an intracranial fluid bioimpedance in a patient's head, to help detect an abnormality, may involve: securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head; measuring the intracranial fluid bioimpedance with the VIPS device by measuring a phase shift between a magnetic field transmitted from a transmitter on one side of a VIPS device and a magnetic field received at a receiver on another side of the VIPS device, at one or more frequencies; and detecting an abnormality in the intracranial bioimpedance fluid, using a processor in the VIPS device.

Abstract: A method for detecting evidence of a stroke in a patient may involve securing a volumetric integral phase-shift spectroscopy (VIPS) device to the patient's head, transmitting a first signal from a first transmitter of the VIPS device through a left hemisphere of the patient's brain to a receiver of the VIPS device, transmitting a second signal from a second transmitter of the VIPS device through a right hemisphere of the patient's brain to the receiver, and detecting the evidence of the stroke, with the VIPS device.

Abstract: A volumetric integral phase-shift spectroscopy (VIPS) device for detecting evidence of a stroke in a patient may include a frame including a housing, at least one VIPS receiver in the housing, circuitry in the housing coupled with the at least one VIPS receiver, two wrap-around ends, configured to wrap around the back of the patient's head and over the ears, a first VIPS transmitter in one of the two wrap-around ends, a second VIPS transmitter in the other of the two wrap-around ends, and a processor. The first and second VIPS transmitters and the at least one VIPS receiver may measure multiple phase shifts and/or multiple amplitudes in a fluid and/or a tissue in the patient's head. The processor may determine that the multiple phase shifts and/or multiple amplitudes matches a predefined stroke-specific VIPS signature and thus detect evidence of a stroke.

Abstract: A device for detecting spatial differences in fluid level changes in a tissue of a patient may include a support structure for securing the device to a body part of the patient, a processing element operably connected to the support structure, a wireless networking interface operably connected to the support structure and in communication with the processing element and an external computing device via a network, a first transmission module operably connected to the support structure and in communication with the processing element, a second transmission module and a third transmission module operably connected to the support structure and in communication with the processing element. When activated, the first transmission module transmits a first time varying magnetic field through the tissue of the patient. The second and third transmission modules, which are spatially separated from one another, receive first and second versions, respectively, of the first time varying magnetic field.